Andrew E. Ajani - Concepedia

Author

Andrew E. Ajani

Also Known As

A AJANI, A Ajani, A E Ajani, A. Ajani, A. E. Ajani, A.E Ajani, A.E. Ajani, ABIOLA JOSHUA AJANI, ANDREW E. AJANI, Abiola Joshua Ajani

480

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

The Royal Melbourne Hospital Monash University The Alfred Hospital The University of Melbourne Geelong Hospital

About

Andrew E. Ajani is an author at The Royal Melbourne Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	58	3.4K
2	Public Health	15	20	1.6K
3	Health Sciences	7	7	214
4	Cardiothoracic Surgery	2	2	137
5	Social Sciences	1	1	86

Andrew E. Ajani

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Shamir R. Mehta, Jean‐François Tanguay, John W. Eikelboom, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseCurrent-oasis 7Coronary Artery Disease	2010	824
Major noncardiac surgery following coronary stenting: When is it safe to operate? Arvind Sharma, Andrew E. Ajani, Shadi M. Hamwi, Catheterization and Cardiovascular Interventions Heart FailureEndovascular TechniqueSurgeryDecember 2000Coronary Artery Disease	2004	208
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial Markus P. Schlaich, M Bellet, Michael A. Weber, The Lancet Molecular PharmacologyHypertensionResistant HypertensionCardiovascular DiseaseAntihypertensive Therapy	2022	206
Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis Ron Waksman, Andrew E. Ajani, Robert L. White, Circulation	2004	186
Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary γ-Radiation in Patients With In-Stent Restenosis Ron Waksman, Andrew E. Ajani, R. Larry White, Circulation	2001	177
Intravascular Gamma Radiation for In-Stent Restenosis in Saphenous-Vein Bypass Grafts Ron Waksman, Andrew E. Ajani, R. Larry White, New England Journal of Medicine	2002	144
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial Clara K Chow, Emily Atkins, Graham S. Hillis, The Lancet HypertensionAntihypertensive TherapyBlood Pressure MedicinesBlood Pressure ControlPharmacotherapy	2021	139
Twelve Versus Six Months of Clopidogrel to Reduce Major Cardiac Events in Patients Undergoing γ-Radiation Therapy for In-Stent Restenosis Ron Waksman, Andrew E. Ajani, Ellen Pinnow, Circulation	2002	130
Is There an Obesity Paradox After Percutaneous Coronary Intervention in the Contemporary Era? T. Lancefield, David Clark, Nick Andrianopoulos, JACC: Cardiovascular Interventions ObesityPercutaneous Coronary InterventionObesity ParadoxCardiovascular DiseaseHealth Policy	2010	125
The Foundation and Launch of the Melbourne Interventional Group: A Collaborative Interventional Cardiology Project Andrew E. Ajani, G. Szto, Stephen J. Duffy, Heart Lung and Circulation Percutaneous Coronary InterventionCardiovascular DiseaseHealth PolicyMelbourne Interventional GroupCoronary Unit	2005	108

Page 1